Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5705332 | Ophthalmology | 2017 | 7 Pages |
Abstract
Our findings demonstrated that MYOC cascade genetic testing for POAG allows identification of at-risk individuals at an early stage or even before signs of glaucoma are present. To our knowledge, this is the first study to demonstrate the clinical utility of predictive genetic testing for MYOC glaucoma.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Emmanuelle MSc, Kien Hou MD, Martin Witney, Jonathan B. MBBS, FRANZCO, Stuart L. PhD, FRANZCO, Paul R. PhD, FRANZCO, Ivan MBBS, FRANZCO, David A. MD, FRANZCO, Alex W. MBBS, PhD, Kathryn P. PhD, Jamie E. DPhil, FRANZCO,